Novartis to speed access to $10 bln heart drug via NHS deal
January 13, 2020 at 13:00 PM EST
Novartis and Britain's National Health Service (NHS) on Monday announced a pact that will clear the way for accelerated review by the country's health watchdog NICE for heart drug inclisiran, which could make it broadly available as soon as 2021.